Skip to content

DISTRIPHAR: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

DISTRIPHAR

BE 0876.852.383
NACE 46.460, Wholesale of pharmaceutical and medical goods
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€62,752
2024 · €14,009-€76,761
Equity
€373,664
2024 · €436,416-€62,752
Cash
€643,560
2024 · €802,289-€158,729
Balance sheet total
€1.1m
2024 · €1.7m-€573,671

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€661,410

    down €661,410 (-79.0%), from €837,441 to €176,031

    of which Trade receivables: -€674,890

  • Stocks and contracts +€244,716

    up €244,716 (+1205.9%), from €20,292 to €265,009

  • Cash -€158,729

    down €158,729 (-19.8%), from €802,289 to €643,560

    mainly Advances received (-€594,494) and Stocks and contracts (-€244,716)

Equity and liabilities
  • Advances received -€594,494

    down €594,494 (-57.7%), from €1.0m to €435,281

  • Trade debts +€96,576

    up €96,576 (+77.4%), from €124,803 to €221,379

  • Profit (loss) carried forward -€62,752

    down €62,752 (-32.3%), from €194,416 to €131,664

Income statement
  • Gross operating margin -€89,333

    down €89,333 (-36.8%), from €242,763 to €153,430

  • Staff costs -€9,450

    down €9,450 (-4.0%), from €238,257 to €228,807

  • Taxes -€4,157

    no longer reported in 2025 (was €4,157)

  • Financial income -€3,812

    down €3,812 (-12.0%), from €31,661 to €27,849

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €14,009
Gross operating margin -€89,333
Staff costs +€9,450
Depreciation +€2,139
Other operating charges +€164
Other operating items -€910
Financial income -€3,812
Financial charges +€1,384
Taxes +€4,157
Result 2025 -€62,752

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€157,619
Investment -€1,110
Financing €0
Cash 2024 €802,289
Net result for the year -€62,752
Depreciation +€3,433
Stocks and contracts -€244,716
Receivables within one year +€661,410
Deferred charges and accrued income -€4,075
Trade debts +€96,576
Tax, wage and social debts -€9,981
Advances received -€594,494
Accrued charges and deferred income -€3,020
Investment in fixed assets (net) -€1,110
Cash 2025 €643,560
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,666,579 €1,092,908 -€573,671 -34.4%
Fixed assets 21/28 €3,332 €1,008 -€2,323 -69.7%
Tangible fixed assets 22/27 €3,332 €1,008 -€2,323 -69.7%
Plant, machinery and equipment 23 €146 €0 -€146 -100.0%
Furniture and vehicles 24 €3,186 €1,008 -€2,177 -68.3%
Current assets 29/58 €1,663,248 €1,091,900 -€571,348 -34.4%
Stocks and contracts in progress 3 €20,292 €265,009 +€244,716 +1205.9%
Stocks 30/36 €20,292 €265,009 +€244,716 +1205.9%
Amounts receivable within one year 40/41 €837,441 €176,031 -€661,410 -79.0%
Trade receivables 40 €816,693 €141,803 -€674,890 -82.6%
Other amounts receivable 41 €20,749 €34,228 +€13,480 +65.0%
Cash at bank and in hand 54/58 €802,289 €643,560 -€158,729 -19.8%
Deferred charges and accrued income 490/1 €3,225 €7,300 +€4,075 +126.4%
Total equity and liabilities 10/49 €1,666,579 €1,092,908 -€573,671 -34.4%
Equity 10/15 €436,416 €373,664 -€62,752 -14.4%
Contributions 10/11 €220,000 €220,000 = 0.0%
Capital 10 €220,000 €220,000 = 0.0%
Issued capital 100 €220,000 €220,000 = 0.0%
Reserves 13 €22,000 €22,000 = 0.0%
Non-distributable reserves 130/1 €22,000 €22,000 = 0.0%
Legal reserve 130 €22,000 €22,000 = 0.0%
Profit (loss) carried forward 14 €194,416 €131,664 -€62,752 -32.3%
Amounts payable 17/49 €1,230,163 €719,244 -€510,919 -41.5%
Amounts payable within one year 42/48 €1,218,128 €710,229 -€507,899 -41.7%
Trade debts 44 €124,803 €221,379 +€96,576 +77.4%
Suppliers 440/4 €124,803 €221,379 +€96,576 +77.4%
Advances received on contracts in progress 46 €1,029,775 €435,281 -€594,494 -57.7%
Taxes, remuneration and social security 45 €43,549 €33,569 -€9,981 -22.9%
Taxes 450/3 €16,320 €8,177 -€8,143 -49.9%
Remuneration and social security 454/9 €27,229 €25,392 -€1,837 -6.7%
Other amounts payable 47/48 €20,000 €20,000 = 0.0%
Accrued charges and deferred income 492/3 €12,035 €9,015 -€3,020 -25.1%
Remuneration, social security and pensions 62 €238,257 €228,807 -€9,450 -4.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €5,572 €3,433 -€2,139 -38.4%
Other operating charges 640/8 €8,041 €7,876 -€164 -2.0%
Non-recurring operating charges 66A - €910 +€910
Gross operating margin 9900 €242,763 €153,430 -€89,333 -36.8%
Operating profit (loss) 9901 -€9,106 -€87,597 -€78,491 -862.0%
Financial income 75/76B €31,661 €27,849 -€3,812 -12.0%
Recurring financial income 75 €31,661 €27,849 -€3,812 -12.0%
Financial charges 65/66B €4,388 €3,005 -€1,384 -31.5%
Recurring financial charges 65 €4,388 €3,005 -€1,384 -31.5%
Profit (loss) for the period before taxes 9903 €18,167 -€62,752 -€80,919
Income taxes 67/77 €4,157 - -€4,157
Profit (loss) for the period 9904 €14,009 -€62,752 -€76,761
Profit (loss) for the period to be appropriated 9905 €14,009 -€62,752 -€76,761

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.